A single medicine oxalic acid or oxalate compositions, or "magic bullet" and methods of treatment and prevention of warm-blooded animals including humans and pets for vascular diseases, disorders, and calcerous conditions, chemoprevention of vascular diseases, disorders, and calcerous conditions, is provided which includes at least one therapeutically effective form of oxalic acid or oxalate selected from oxalic acid in a free acid, ester, lactone or salt form and oxalate including sodium oxalate, oxalic acid dihydrate, anhydrous oxalic acid, oxamide, and oxalate salts, natural or processed foods including molds, plants or vegetables containing oxalic acid or oxalate, beverages, liquids or juices containing oxalic acid or oxalate, additives containing oxalic acid or oxalate, and combinations thereof. The compositions may also contain a pharmaceutically acceptable carrier or diluent for the therapeutically effective form of oxalic acid or oxalate. Methods are provided including the steps of periodically administering, by topical, oral, or parenteral application, a therapeutically effective dosage of a composition including at least one therapeutically effective form of oxalic acid or oxalate in less than a lethal dosage and improving chemotherapy by reducing the intake of oxalic acid or oxalate blockers such as citric acid, ascorbic acid (vitamin C), pyridoxine hydrochloride (vitamin B6), calcium, alcohol, resins, clays, foods containing calcium, beverages containing alcohol, citric, or ascorbic acid, red meat or white meat of fowl containing pyridoxine hydrochloride, or other foods, nutritional supplements or beverages containing oxalic acid or oxalate blockers.
CROSS-REFERENCE TO RELATED APPLICATIONS
This Application is a Continuation-in-Part of U.S. application Ser. No. 09/014,943, filed Jan. 28, 1998, now U.S. Pat. No. 6,133,318, hereby incorporated by reference. Also this Application is a Continuation-in-Part of U.S. Provisional Application Serial No. 60/036,983, filed Jan. 29, 1997, hereby incorporated by reference. Also, this Application is a Continuation-in-Part of U.S. application Ser. No. 08/629,538, filed Apr. 9, 1996, now U.S. Pat. No. 6,133,317 which is a Continuation-in-Part of U.S. Provisional Application Serial No. 60/006,785, filed Nov. 15, 1995, hereby incorporated by reference.
A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary levels, the nicotinamide being delivered in combination with zinc. The composition may also include quantities of copper and folic acid. In a most preferred embodiment, the nicotinamide and copper each are present in immediate release formats, while the zinc is present in a sustained release format.
The present invention discloses tissue products comprising a cleansing composition. The cleansing composition removes soil and contaminants from the skin's surface and comprises a thermoplastic polymer and a water soluble neutral oligosaccharide. In one embodiment, the cleansing composition comprises polymethylmethacrylate and a water soluble starch.
